Quantcast

Latest biotechnology Stories

2014-08-14 04:21:38

WASHINGTON, NEW YORK, and LONDON, Aug. 14, 2014 /PRNewswire/ -- As a leading provider of market research solutions, MarketResearch.com is pleased to announce the addition of new content to its Kalorama Information Biotechnology Knowledge Center. http://photos.prnewswire.com/prnvar/20140801/132627 The Biotechnology Knowledge Center allows clients unlimited access to browse and download biotechnology market research reports in an easy-to-use platform with an entire library of reports from...

2014-08-13 23:06:41

The global molecular biology enzymes market comprises of the applications, end-user and products segments. http://www.marketsandmarkets.com/Market-Reports/molecular-biology-enzymes-kits-reagents-market-164131709.html (PRWEB) August 13, 2014 The “Molecular Biology Enzymes, Kits, & Reagents Market by Application (Cloning, Epigenetics, PCR, Restriction Digestion, Sequencing), Product (Ligase, Phosphatase, Polymerase, Protease, Restriction Endonuclease, Reverse Transcriptase) - Global...

2014-08-13 23:06:33

DeepResearchReports.com adds “2014 Deep Research Report on Global and China Surfactant Industry” report to its research database. Dallas, Texas (PRWEB) August 13, 2014 "2014 Deep Research Report on Global and China Surfactant Industry” is a professional and in-depth research report on Surfactant market. The report provides Surfactant information, including its definition, classification, application, and industry chain structure as well as industry overview. This research...

2014-08-13 16:26:19

BOULDER, Colo., Aug. 13, 2014 /PRNewswire/ -- BiOptix announced today an additional $1.4M financing from existing investors. The funds will be used to expand sales and marketing and ramp up manufacturing to meet growing customer demand. Rick Whitcomb, President and CEO of BiOptix, noted: "This latest increase in capital shows that our investors are confident in our plan and our team, and that BiOptix is on a solid path to commercial success." BiOptix continues to see opportunity...

2014-08-13 16:26:06

SHANGHAI, Aug. 13, 2014 /PRNewswire/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading research and development services company serving the pharmaceutical, biotechnology, and medical device industries, with operations in China and the United States, today announced its financial results for the second quarter of 2014. Second-Quarter 2014 Highlights -- Net Revenues Increased 14.8% Year Over Year to $163.4 Million -- Laboratory Services Net Revenues Grew 13.2% Year Over Year...

2014-08-13 08:29:58

Phase III Trial Is Alive And Well; "Hint Of Failure" A Complete Fabrication; No Interim Analysis of Efficacy Done; 55 Patients' Positive Data Independently Collected. BETHESDA, Md., Aug. 13, 2014 /PRNewswire/ -- Northwest Biotherapeutics (NASDAQ: NWBO) (NW Bio), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, today corrected ongoing false claims by Adam Feuerstein published on the TheStreet.com about the Company's Phase III trial of DCVax-L...

2014-08-13 08:29:09

New Drug Development Efforts for Novel Cancer Treatments ORLANDO, Fla. and HUBEI, China, Aug. 13, 2014 /PRNewswire/ -- TNI BioTech, Inc. (OTC: TNIB) ("TNI" or the "Company") a biotechnology company pioneering the manufacturing and marketing of innovative therapies for autoimmune diseases in emerging nations, announced today the signing of a supplemental agreement with Hubei Qianjiang Pharmaceutical Co., Ltd (SHSE:600568) ( Qianjiang) China on behalf of Cytocom, TNI BioTech's wholly owed...

2014-08-12 16:28:21

WOBURN, Mass., Aug. 12, 2014 /PRNewswire/ -- Covaris, Inc. announced the introduction of the patent-pending microTUBE LV, its latest product designed for low volume, high performance DNA Shearing for Next Generation Sequencing (NGS) applications. The Covaris microTUBE LV allows researchers to process samples as small as 15 microliters using Adaptive Focused Acoustics (AFA(TM)) which has become the "gold standard" in genome research and clinical centers worldwide. "Molecular...

2014-08-12 16:27:31

DUBLIN, Aug. 12, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Biological Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020" report to their offering. http://photos.prnewswire.com/prnh/20130307/600769 Biological drugs are typically derived from living cells and are used in the treatment and prevention of various diseases such as cancer, blood-related diseases, auto-immune diseases and other medical disorders....

2014-08-12 16:25:15

LONDON, Aug. 12, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Global Biorefinery Market 2014-2018.pdfhttps://www.reportbuyer.com/product/2170338/Global-Biorefinery-Market-2014-2018pdf.htmlAbout BiorefineryA biorefinery is a facility that is used for converting biomass into fuels, power, heat and chemicals. Chemicals such as acetic acid, liquid fuel such as bioethanol and biodegradable plastics such as polyhydroxyalkanoates can be produced from...


Latest biotechnology Reference Libraries

GloFish
2013-10-03 10:12:03

The GloFish is a patented and trademarked brand of genetically modified fluorescent fish. Various GloFish are currently on the market. Zebrafish were the first GloFish that were available within pet stores and are now sold in bright green, red, orange-yellow, blue, and purple fluorescent colors. Recently, Electric Green, Sunburst Orange, and Moonrise Pink colored tetra (Gymnocorymbus ternetzi) and Electric Green tiger barb (Puntius tetrazona) have been incorporated to the lineup. Although not...

Flavr Savr
2013-10-03 09:43:32

Flavr Savr, also known as CGN-89564, a genetically modified tomato, was the first commercially grown genetically engineered food to be granted a license for human consumption. It was produced by the Californian company Calgene, and submitted to the U.S. Food and Drug Administration in 1992. On May 18, 1994, the FDA completed its evaluation of the Flavr Savr tomato and the usage of APH(3’)II, concluding that the tomato “is as safe as tomatoes bred by conventional means” and “that the...

Knockout Mouse
2013-10-02 11:52:01

A Knockout Mouse is a genetically engineered mouse in which researchers have inactivated, or “knocked out,” an existing gene by replacing it or disrupting it with an artificial piece of DNA. The loss of gene activity frequently causes changes in a mouse’s phenotype, which includes appearance, behavior, or other apparent and biochemical characteristics. Knockout mice are significant animal models for studying the role of genes which have been sequenced but whose functions haven’t...

Genetically Modified Wheat
2013-10-02 07:20:35

Genetically Modified Wheat is wheat that has been genetically engineered by the direct manipulation of its genome utilizing biotechnology. It has also been termed GMO wheat, GMO standing for genetically modified organism. As of the year 2013, no GM wheat is grown commercially, but many field tests have been performed. Wheat is an important domesticated grass that is used around the world for food, and its evolution has been influenced by human intervention since the dawn of agriculture....

Biotechnology and Applied Biochemistry
2012-06-04 19:33:04

Biotechnology and Applied Biochemistry is a peer-reviewed academic journal established in 1979 under the title Journal of Applied Biochemistry and published by Academic Press. It assumed its present title in 1986 and publication was taken over by Portland Press in 1993. It is now published bimonthly by Wiley-Blackwell (since 2011). It is the official journal of the International Union of Biochemistry and Molecular Biology. The journal publishes scholarly Articles and Reviews relating to...

More Articles (7 articles) »
Word of the Day
pungle
  • To take pains; labor assiduously with little progress.
This word comes from the Spanish 'pongale,' put it.
Related